After 30 years of sustained high-speed development, China's medical device industry has initially established an industrial system with complete professional categories, perfect industrial chain and strong industrial base. China has surpassed Japan to become the world's second largest medical device market.
According to the "2018-2020 China Health Industry Investment Research Report" data: Since the beginning of the 21st century, China's medical device industry has entered a stage of rapid growth, with a total sales volume of 17.9 billion yuan in 2001, and approximately 255.6 billion in 2014. Yuan, an increase of 14.28 times. From 2010 to 2016, the domestic medical device market grew from 126 billion yuan in 2010 to 370 billion yuan in 2016, with a compound annual growth rate of 19.67%. In 2017, China's medical device market has exceeded 400 billion. yuan.
Although the sales volume of the domestic medical device market is growing rapidly, the consumption ratio of drugs and medical devices in 2015 is only 1:0.33, far lower than the global average of 1:0.7, which is lower than that of developed countries. The level of .02:1, so the development of the domestic medical device market is broad, and the market is far from saturated.
2011-2016 China medical device market scale (100 million yuan)
First, the four major problems in China's medical device enterprises
1. Domestic brand low-price bidding strategy. Lack of strategic positioning, lower than the benchmark high-end products, and the simultaneous compression of profits with agents.
The competition is at a disadvantage, there is not enough profit to continue research and development, lack of financial support, and upgrades also face technical and financial pressure, and the market brand investment is insufficient.
2. A single technological breakthrough is difficult to form a platform advantage. Lack of long-term technology combination, dilute customer development costs, and dare not invest in training and development of customers.
3. There is a technical detail gap in the simple imitation process. The shape is similar and the god is not like, the quality is uneven. With the localization of the production of imported products, domestic enterprises should truly master the technology and product research and development ideas. Key raw materials, high-precision processing equipment and technical mastery can significantly shorten the gap.
4. Quality control puts forward higher requirements. Medical device safety is placed in front of the benefits. The product development and technical change stages must be verified and confirmed. The system must ensure the stability of the product in batches and can be continuously improved. According to the official website of the State Food and Drug Administration, since January 1, 2018, the "Measures for the Administration of Conditions and Filing of Medical Device Clinical Trial Organizations" has been officially put into effect.
2011-2016 global medical device sales scale (100 million US dollars)
Second, China's medical equipment is less than the disadvantages and advantages of foreign countries
There is a certain gap between the scale of China's medical device market and foreign countries, but the growth rate is amazing:
In 2016, the global market for medical devices was 40.63 billion US dollars. The US market has the largest scale, reaching 208.4 billion US dollars. The market size of China is 370 billion yuan, accounting for 1/6 of the global market. The growth rate of medical devices in the United States is only 6.03%, while China's growth rate is around 19.67%.
Global medical devices account for 42% of the total size of the pharmaceutical market, while China's medical devices account for 9.16% of the total pharmaceutical market. China's medical device industry still has a lot of room for development.
China's medical device companies have a huge gap compared to the US, but their growth rate is much higher than the US and global average. In 2016, the revenue of China's TOP10 medical device companies increased by 30% year-on-year, while the US figure was only 6.84%.
There is a big gap between absolute investment and relative investment in the United States:
In 2016, the total investment in research and development of TOP10 companies in the US medical device revenue was US$10.4 billion, accounting for 8.14% of total revenue. In the same period, the total investment in research and development of TOP10 enterprises in China's medical device revenue was 1.806 billion yuan, accounting for 5.35% of total revenue.
The gaps in research and development at home and abroad are mainly reflected in the lack of volume, product originality, technical details, core materials and key components. The cooperative research and development model of domestic industry and clinical demand is gradually maturing, and the original products are relatively scarce.
Third, in the next three years, the space for in vitro diagnosis, neurology, and cardiac device market development is full of imagination.
In vitro diagnostics continues to lead medical devices, accounting for 13.1% of total industry sales. By 2020, in vitro diagnostics will remain the largest submarket in the medical device market.
Cardiac medical devices rank second, followed by traditional industries such as diagnostic imaging, orthopedics and ophthalmology.
Neurology is the fastest growing submarket in medical devices. The rapid growth of the medical device market is also because many diseases are difficult to solve with drugs, so medical diagnosis, neuromodulation, etc. will contribute to the diagnosis and treatment of diseases.
Overall, investing in medical innovation technology will be the future trend. In China's future market, domestic import substitution is the trend of the times, and the national policy is also tilting toward domestic equipment. Overseas, cost-effective Chinese manufacturing will challenge the international brands as early as possible globally. Globally, it will truly break through the bottleneck of the development of medical devices, deepen clinical research, new materials, new technology and other basic disciplines, and combine artificial intelligence and other emerging disciplines to accelerate technology iteration.
Introduction:
Our farmland has fertile soil,sufficient sun-light,ample rainfall,and far away from urban pollution,traditional planting methods,artificial weeding,standardized pesticide residues.
Our pure White Garlic,keep freshness and nutrition to the greatest extent
With the advantages of good condition,pure flavor,strong aroma,high allicin etc.
More knowledge:
The bulb of garlic,an allium plant in the lily family.with the pungent flavor and spicy taste.spherical shape with a diameter of 3-6.5cm. The surface is covered with white and papery-skin.
The top is slightly pointed, with residual scape in the middle,many fibrous root marks at the base. The bulbous valve is slightly ovoid, with a membranous outer skin, slightly pointed at the apex, and an arcuate bulge on one side.
Specification:
1.Brand:Changrong
2.Variety:Liliaceous Vegetables
3.Color:Pure white/Normal white
4.Nutrition
Manganese: 2% of the Daily Value
Vitamin C: 1% of the Daily Value
Selenium: 1% of the Daily Value
Fiber: 0.06 grams
Decent amounts of calcium, copper, potassium, phosphorus, iron and vitamin B1
Organic White Garlic,Silver White Garlic,Organic White Garlic Seed,Organic White Garlic Powder
shandong changrong international trade co.,ltd. , https://www.changronggarliccn.com